The relationship between golfing and the cannabidiol (CBD) industry took another step forward on Tuesday (January 21) as a producer was tapped as a sponsor for an upcoming tournament.

The Farmers Insurance Open, an official tournament that is part of the PGA Golf tour, confirmed CV Sciences’ (OTCQB:CVSI) PlusCBD Oil brand of products as a sponsor of the event.


The tournament, which starts this Thursday (January 23) at Torrey Pines in San Diego, California, will attract some of the top talent the PGA has to offer as it is one of the first big events of the golf season.

“We believe both professional and amateur golfers can benefit from PlusCBD Oil products and we look forward to increasing our visibility among the golf community through this sponsorship,” Joseph Dowling, CEO of CV Sciences, said in a statement.

For the CBD producer, this marks a critical development in the adoption of CBD as part of professional athletes’ everyday routines. Particularly, golfing has become a proponent of CBD use among active players.

According to CV Sciences, golf players have picked up CBD use as a way to engage with recovery in terms of general aches and pains to the body, and also as a way to help with muscle relaxation.

In addition to the general sponsorship agreement, the CBD producer will maintain a booth for attendants of the tournament.

The CBD industry has only been upgrading its ties with the sport of golf recently. Last year, cbdMD (NYSEAMERICAN:YCBD) inked a sponsor partnership with professional golfer Bubba Watson. The player agreed to incorporate the logo of the company as part of his official playing attire.

The decision from Watson did not come as a surprise as many players have embraced the potential attached to CBD for their own recoveries. In an ESPN report, players outlined how using CBD has changed their health patterns.

“The players are comfortable with a low THC count. That was the main thing I had a hesitancy about, what is their response to putting something in their bodies that’s new? …” Steve Patterson, director of sales at Functional Remedies EndoSport, told ESPN. “But it’s also a natural product, so then word of mouth, it really took off. That’s where the popularity and acceptance has come in.”

Last year, Functional Remedies EndoSport touted having nearly 100 professional golf players under its sponsor umbrella.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less